SynthesisFrontiers in immunology2025

Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.

Na Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.